Abstract:Non-small cell lung cancer (NSCLC) exhibits radioresistance to conventional rays, due to its DNA damage repair systems. NSCLC may potentially be sensitized to radiation treatment by reducing those factors that continuously enhance the repair of damaged DNA. In the present study, normal lung fibroblast MRC-5 and lung cancer A549 cells were treated with NU7026 and CGK733, which are inhibitors of the DNA-dependent protein kinase catalytic subunit (PKcs) and ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR), respectively, followed by exposure to X-rays and carbon ion irradiation. The cytotoxic activity, cell survival rate, DNA damage repair ability, cell cycle arrest and apoptosis rate of the treated cells were analyzed with MTT assay, colony formation assay, immunofluorescence and flow cytometry, respectively. The transcription and translation levels of the ATM, ATR and DNA-PKcs genes were detected by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The results indicated that the radiosensitivity and DNA repair ability of A549 cells were reduced, and the percentages of apoptotic cells and those arrested at the G(2)/M phase of the cell cycle were significantly increased, following ionizing radiation with inhibitor-pretreatment. The expression levels of ATM, ATR, DNA-PKcs and phosphorylated histone H2AX, a biomarker for DNA double-strand breaks, were all upregulated at the transcriptional or translational level in A549 cells treated with carbon ion irradiation, compared with the control and X-rays-treated cells. In addition, the treatment with 5-50 mu M NU7026 or CGK733 did not produce any obvious cytotoxicity in MRC-5 cells, and the effect of the DNA-PKcs-inhibitor on enhancing the radiosensitivity of A549 cells was stronger than that observed for the ATM and ATR-inhibitor. These findings demonstrated a minor role for ATM and ATR in radiation-induced cell death, since the upregulation of ATM and ATR did not rescue the A549 cells subjected to ionizing irradiation. Therefore, future studies on DNA-PKcs, ATM and ATR may lead to novel specific therapies that supplement general radiotherapy for the treatment of lung cancer.

LKB1 Mutations Enhance Radiosensitivity in Non-Small Cell Lung Cancer Cells by Inducing G2/M Cell Cycle Phase Arrest

Silencing of Heat Shock Protein 27 Increases the Radiosensitivity of Non‑small Cell Lung Carcinoma Cells.

Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway

Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer

LKB1 Gene Inactivation Does Not Sensitize Non-Small Cell Lung Cancer Cells to Mtor Inhibitors in Vitro

Suppresses of LIM Kinase 2 Promotes Radiosensitivity in Radioresistant Non-Small Cell Lung Cancer Cells

Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer

Endogenous LKB1 Knockdown Accelerates G1/S Transition Through P53 and P16 Pathways

Association of Protein Kinase CK2 Inhibition with Cellular Radiosensitivity of Non-Small Cell Lung Cancer

LKB1 is a DNA damage response protein that regulates cellular sensitivity to PARP inhibitors.

Overexpression of the LKB1 Gene Inhibits Lung Carcinoma Cell Proliferation Partly Through Degradation of C-Myc Protein.

LKB1 Modulates Lung Cancer Differentiation and Metastasis.

[Function and Prognostic Value of Tumor Suppressor Gene LKB1 in Human Breast Carcinoma].

Inhibition of DNA-PKcs Enhances Radiosensitivity and Increases the Levels of ATM and ATR in NSCLC Cells Exposed to Carbon Ion Irradiation.

LIMD1 Radiosensitizes Human Non-Small Cell Lung Cancer Cells Via Inhibiting NF-kB Signaling

Liver Kinase B1 Enhances Chemoresistance to Gemcitabine in Breast Cancer MDA-MB-231 Cells

NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.

Epidermal Growth Factor Receptor Gene Mutations in Non-Small-cell Lung Cancer Cells Are Associated with Increased Radiosensitivity in Vitro

Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.

Reduced Expression of Liver Kinase B1 and Beclin1 is Associated with the Poor Survival of Patients with Non-Small Cell Lung Cancer

LILRB2 Inhibition Enhances Radiation Sensitivity in Non-Small Cell Lung Cancer by Attenuating Radiation-Induced Senescence